Liver Impairment—The Potential Application of Volatile Organic Compounds in Hepatology
Open Access
- 11 September 2021
- journal article
- review article
- Published by MDPI AG in Metabolites
- Vol. 11 (9) , 618
Abstract
Liver diseases are currently diagnosed through liver biopsy. Its invasiveness, costs, and relatively low diagnostic accuracy require new techniques to be sought. Analysis of volatile organic compounds (VOCs) in human bio-matrices has received a lot of attention. It is known that a musty odour characterises liver impairment, resulting in the elucidation of volatile chemicals in the breath and other body fluids such as urine and stool, which may serve as biomarkers of a disease. Aims: This study aims to review all the studies found in the literature regarding VOCs in liver diseases, and to summarise all the identified compounds that could be used as diagnostic or prognostic biomarkers. The literature search was conducted on ScienceDirect and PubMed, and each eligible publication was qualitatively assessed by two independent evaluators using the SANRA critical appraisal tool. Results: In the search, 58 publications were found, and 28 were kept for inclusion: 23 were about VOCs in the breath, one in the bile, three in urine, and one in faeces. Each publication was graded from zero to ten. A graphical summary of the metabolic pathways showcasing the known liver disease-related VOCs and suggestions on how VOC analysis on liver impairment could be applied in clinical practice are given.Keywords
Funding Information
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (016 VENI 178.064)
This publication has 76 references indexed in Scilit:
- Rapid “Breath-Print” of Liver Cirrhosis by Proton Transfer Reaction Time-of-Flight Mass Spectrometry. A Pilot Study.PLOS ONE, 2013
- Breath volatile analysis from patients diagnosed with harmful drinking, cirrhosis and hepatic encephalopathy: a pilot studyMetabolomics, 2013
- Breath biomarkers of liver cirrhosisJournal of Chromatography B, 2012
- The Screening of Volatile Markers for Hepatocellular CarcinomaCancer Epidemiology, Biomarkers & Prevention, 2010
- Breath biomarkers and non-alcoholic fatty liver disease: Preliminary observationsBiomarkers, 2006
- Breath analysis in critically ill patients: potential and limitationsExpert Review of Molecular Diagnostics, 2004
- Diagnostic potential of breath analysis—focus on volatile organic compoundsClinica Chimica Acta, 2004
- A Model to Predict Survival in Patients With End–Stage Liver DiseaseHepatology, 2001
- Limonene in expired lung air of patients with liver diseaseDigestive Diseases and Sciences, 1994
- Quantitative Analysis of Urine Vapor and Breath by Gas-Liquid Partition ChromatographyProceedings of the National Academy of Sciences, 1971